Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 179, Issue 3, 1999, Pages 637-645

  Ravn, Pernille ^a,b,c,d,e,f   Demissie, Abebech ^a,b,c,d,e,f   Eguale, Tewodros ^a,b,c,d,e,f   Wondwosson, Hailu ^a,b,c,d,e,f   Lein, David ^a,b,c,d,e,f   Amoudy, Hanady A ^a,b,c,d,e,f   Mustafa, Abu S ^a,b,c,d,e,f   Jensen, Axel Kok ^a,b,c,d,e,f   Holm, Arne ^a,b,c,d,e,f   Rosenkrands, Ida ^a,b,c,d,e,f   Oftung, Fredrik ^a,b,c,d,e,f   Olobo, Joseph ^a,b,c,d,e,f   Von Reyn, Fordham ^a,b,c,d,e,f   Andersen, Peter ^{a,b,c,d,e,f,g}  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^d Hossana District Hospital   (Ethiopia)

^e DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^f NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^g STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; MYCOBACTERIUM ANTIGEN; TUBERCULIN;

ANTIGEN RECOGNITION; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; DENMARK; ENDEMIC DISEASE; ETHIOPIA; HLA SYSTEM; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TUBERCULIN TEST;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CELLS, CULTURED; DENMARK; EPITOPES; ETHIOPIA; HUMANS; INTERFERON TYPE II; KUWAIT; MYCOBACTERIUM TUBERCULOSIS; REFERENCE VALUES; T-LYMPHOCYTES; TUBERCULOSIS; UNITED STATES;

EID: 0033394970     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314640     Document Type: Article

References (47)

1. 1. Kochi A. Tuberculosis: distribution, risk factors, mortality. Immunobiology 1994; 191:325-36.
2. 2. Leroy V, Salmi LR, Dupon M, et al. Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. Am J Epidemiol 1997; 145:293-300.
3. 3. Pal PG, Horwitz MA. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect Immun 1992; 60:4781-92.
4. 4. Hubbard RD, Flory CM, Collins FM. Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol 1992; 87:94-8
5. 5. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62:2536-44.
6. 6. Roberts AD, Sonnenberg MG, Ordway DJ, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995; 85: 502-8.
7. 7. Horwitz MA, Lee BW, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995; 92:1530-4.
8. 8. Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995; 154:3359-72.
9. 9. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63:1710-7.
10. 10. Brandt L, Oettinger T, Holm A, Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996; 157:3527-33.
11. 11. Haslov K, Andersen A, Nagai S, Gottschau A, Sorensen T, Andersen P. Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63:804-10.
12. 12. Elhay MJ, Oettinger T, Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the Guinea pig. Infect Immun 1998; 66:3454-6.
13. 13. Pollock JM, Andersen P. Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun 1997; 65:2587-92.
14. 14. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64:16-22.
15. 15. Pollock JM, Andersen P. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis 1997; 175:1251-4.
16. 16. National Tuberculosis and Respiratory Disease Association. Diagnostic standards and classification of tuberculosis. National Tuberculosis and Respiratory Disease Association, 1969.
17. 17. Poulsen S, Miörner H. Tuberculosis 1995. EPI-NEWS 1996.
18. 18. Ravn P, Boesen H, Pedersen BK, Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J Immunol 1997; 158:1949-55.
19. + lymphocytes from healthy HIV-seropositive and -seronegative individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:433-41.
20. 20. Mustafa AS, Amoudy HA, Wiker HG, et al. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol 1998; 48:535-43.
21. 21. von Reyn CF, Green PA, McCormick D, et al. Dual skin testing with M. avium sensitin and PPD: an open study in patients with Mycobacterium avium complex infection or tuberculosis. Clin Infect Dis 1994; 19:15-20.
22. 22. von Reyn CF, Williams D, Horsburgh CR, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177:730-6.
23. 23. Streeton JA, Desem N, Jones SL. Sensitivity and specificity of a gamma-interferon blood test for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 443-50.
24. 24. Dockrell HM, Weir RE. Whole blood cytokine assays - a new generation of diagnostic tests for tuberculosis? Int J Tuberc Lung Dis 1998; 2:441-2.
25. 25. Onwubalili JK, Scott GM, Robinson JA. Deficient immune interferon production in tuberculosis. Clin Exp Immunol 1985; 59:405-8.
26. + T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989; 142:1114-9.
27. 27. Havlir DV, Wallis RS, Boom WH, Daniel TM, Chervenak K, Ellner JJ. Human immune response to Mycobacterium tuberculosis antigens. Infect Immun 1991; 59:665-70.
28. 28. Torres M, Mendez-Sampeiro P, Jimenez-Zamudio L, et al. Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 1994; 96:75-8.
29. 29. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995; 63:3231-4.
30. 30. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ. Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA 1996; 93:3193-8.
31. 31. Ellner JJ. Review: the immune response in human tuberculosis - implications for tuberculosis control. J Infect Dis 1997; 176:1351-9.
32. 32. Boesen H, Jensen BN, Wilcke T, Andersen P. Human T cell responses to secreted antigens fractions of Mycobacterium tuberculosis. Infect Immun 1995; 63:1491-7.
33. 33. Sodhi A, Gong J, Silva C, Qian D, Barnes PF. Clinical correlates of interferon gamma production with tuberculosis. Clin Infect Dis 1997; 25:617-20.
34. 34. Lorgat F, Keraan MM, Ress SR. Cellular immunity in tuberculous pleural effusions: evidence of spontaneous lymphocyte proliferation and antigen-specific accelerated responses to purified protein derivative (PPD). Clin Exp Immunol 1992; 90:215-8.
35. 35. Lorgat F, Keraan MM, Lukey PT, Ress SR. Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992; 145:418-23.
36. 36. Manca F, Rossi G, Valle MT, et al. Limited clonal heterogeneity of antigen-specific T cells localizing in the pleural space during mycobacterial infection. Infect Immun 1991; 59:503-13.
37. + T cells of mycobacteria growing in human macrophages. Science 1993; 260:984-6.
38. 38. Mainali ES, McMurray DN. Protein deficiency induces alterations in the distribution of T cell subsets in experimental pulmonary tuberculosis. Infect Immun 1998; 66:927-31.
39. 39. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-9.
40. 40. Goldfeld AE, Delgado JC, Thim S, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279:226-8.
41. + T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95:270-5.
42. 42. Charron D. Genetic diversity of HLA functional and medical implication. In: Charron D. Anthropology: contribution of HLA. Sévres, France: Medical and Scientific International Publisher, 1997:344-53.
43. 43. Fort M, De Stefano GF, Cambon-Thomsen A, et al. HLA class II allele and haplotype frequencies in Ethiopian Amhara and Oromo populations. Tissue Antigens 1998; 51:327-36.
44. 44. Lindblom B, Svejgaard A. HLA genes and haplotypes in the Scandinavian populations. In: Tsuji K, Aizawa M, Sasazuki T. Proceedings of the eleventh international histocompatibility workshop and conference. Oxford, UK: Oxford Science Publications, 1991:651-5.
45. 45. Meister GE, Roberts CG, Berzofsky JA, De Groot AS. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Vaccine 1995; 13:581-91.
46. 46. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR allele. J Exp Med 1993; 178:27-47.
47. 47. Meyer C, May J, Schnittger L. HLA-DP-part of the concert. Immunol Today 1997; 18:58-61.